查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
生物打印：市場和機遇
市場調查報告書
商品編碼
1134398

生物打印：市場和機遇

Bioprinting: Markets and Opportunities
出版日期: | 出版商: Additive Manufacturing Research | 英文 107 Pages | 訂單完成後即時交付

價格
簡介目錄

目前，生物打印領域有100多家公司，其中大部分僅產生少量收入。

另一方面，生物打印的新應用領域正在迅速湧現，這非常符合醫學的重要大趨勢，特別是個性化醫療和“貼近患者”的趨勢。例如，生物打印允許在診所而不是專科醫院進行皮膚移植等程序。

本報告分析了全球生物打印市場的趨勢和機遇，包括市場的基本結構、主要驅動和製約因素、主要應用領域、技術概況和未來發展機會，以及相關技術（生物打印）、墨水等.) 主要公司的市場趨勢、概況和業務戰略，以及其他信息。

內容

第 1 章概述

  • 報告背景：生物打印的複興？
  • 生物打印：極具吸引力的未來商機
    • 歷史與展望
    • 生物打印行業的結構
    • 生物打印行業的演變
  • 公司的地域多樣性
  • 本報告的目的、範圍和計劃
  • 本報告中使用的研究方法
  • 本章重點

第 2 章生物打印：市場驅動因素和挑戰

  • 導致“生物打印時刻”的因素
  • 新型冠狀病毒病 (COVID-19) 的影響因素：COVID-19 是生物打印市場的驅動因素
  • 人口老齡化：生物打印的作用
  • 生物打印和個性化醫療：讓藥物更貼近患者
  • 從之前的“生物打印時刻”中湧現出的新技術
    • 生物打印技術進步面臨的挑戰
  • 增加建模的可能性
  • 政府監管和資金的影響
  • 種類繁多的生物墨水
  • 生物打印的倫理問題
  • 本章重點

第 3 章生物打印機：技術和市場演變

  • 生物打印機的精髓
  • 擠壓式生物打印機
    • 擠壓式生物打印機示例
    • 擠壓生物打印的未來
  • 噴墨生物打印機
    • 用於生物打印的熱噴墨
    • 用於生物打印的壓電噴墨
    • Rastrum Bioprinter：噴墨打印機示例
  • 立體光刻 (SLA)
    • 基於 SLA 的生物打印問題
    • SLA 生物打印機製造商
  • 其他生物打印技術
  • 生物打印機市場的未來預測（未來 10 年）：按技術和打印機類型
    • 從研究型生物打印到生物製造：未來預測
  • 本章重點

第 4 章生物墨水

  • 生物墨水簡介
    • 支持/支持的生物打印
    • 水凝膠
    • 幹細胞和生物打印
    • 球體和類器官
    • 陶瓷和生物打印
    • 剪切打印注意事項
  • 生物墨水的類型：按功能
    • 犧牲性生物墨水
    • 功能性生物墨水
    • 支持性生物墨水
  • 生物墨水材料
    • 瓊脂糖
    • 海藻酸鹽
    • 膠原蛋白
    • 明膠
    • 德國
    • 殼聚醣
    • 透明質酸
    • DECCM
    • 纖維蛋白
    • 纖維素
    • 絲綢
    • 基於細胞外基質 (ECM) 的生物墨水
    • 合成聚合物的作用
    • 智能生物墨水和具有先進材料添加劑的生物墨水
  • 逐步淘汰動物成分
  • Bioink 供應鍊和供應商
  • 本章重點

第五章生物打印的主要應用領域

  • 生物打印應用領域分析：簡介
  • 生物打印和改進的醫學建模
    • 器官芯片
    • 疾病建模
  • 生物打印皮膚
    • 植皮背景
    • 生物打印和燒傷受害者
    • 用於皮膚生物打印的 Bioink
    • 化妝品檢測
  • 骨/軟骨打印
    • 用於骨骼/軟骨打印的材料
  • 器官和血管的打印
    • 印刷和活體器官之間的競爭
    • 膀胱印
    • 生物打印和乳房植入物
    • 肝紋
    • 內分泌系統
    • 印刷胰腺
    • 腎臟生物打印
    • 肺
    • 耳朵和鼻子
    • 眼睛
    • 心臟和血管系統
    • 生物打印和神經組織
  • 生物打印在牙科應用中的注意事項
  • 本章重點

第 6 章生物打印的新方向

  • 簡介
  • 軟機器人
    • 使用生物材料的軟機器人和打印
  • 食品印刷
    • 食品印刷的驅動力
    • 食品打印機和食品設計
    • 目前正在銷售的食品打印機
    • 肉類生物打印
    • 糖果和巧克力印刷
    • 3D 打印主題餐廳
  • 平板印刷
    • 使用 3D 打印製造平板電腦：利弊
    • 增長的產業結構
  • 關於醫療設備的注意事項
  • 本章重點

第 7 章。9 家主要生物打印公司：概況和戰略

  • 分析標準
  • 3DBio Therapeutics：面向醫療保健提供者的完整生物打印套件
  • 3D Systems/Systemic Bio：生物打印業務仍在摸索中
  • BICO (Cellink)：生物融合集團
  • Cyfuse：日本生物打印公司
  • EnvisionTEC/Desktop Metal：對生物打印的興趣日益濃厚
  • FluidForm：利用尖端技術與大公司建立關係
  • Inventia 生命科學：脫離研發 (R&D)
  • Organovo Holdings：比以往更加專注
  • Rokit Healthcare：韓國生物打印和 Google Cloud

關於SmartTech分析

關於分析師

本報告中使用的首字母縮略詞和縮略語

簡介目錄
Product Code: SMP-BIO2022-1022

SmarTech has been tracking the bioprinting industry for almost a decade and this is its third major bioprinting report. The report covers bioinks and bio-printing related applications, as well as well as the bioprinters themselves. Applications discussed in the report include drug discovery and testing, cosmetics testing, tissue and bone printing. We also examine the long-term prospects for transplanting bioprinted organs. And there is a chapter on new directions for bioprinting including discussions on soft robotics, pill printing, printed food.

The new SmarTech report provides a realistic assessment of bioprinting's commercial future including analysis of what the major bioprinting companies are designing their marketing strategies. In addition to the pure play bioprinting companies, the bioprinting sector is seeing involvement from major life science companies and 3D printing companies. There are now well over 100 firms in the bioprinting sector, but most of these companies have negligible revenues. Among the firms that are discussed in this report are 3DBio Therapeutics, 3D Systems/Systemic Bio, BICO (Cellink), Collplant, Cyfuse, EnvisionTEC/Desktop Metal, FluidForm, Inventia Life Science, Organovo Holdings, Poietis, Regamat, Rokit Healthcare and many others.

According to Lawrence Gasman , Founder of SmarTech Analysis and author of the report, "New applications are quickly emerging for bioprinting, and they are very much in line with important megatrends in healthcare-notably the trends towards personalized medicine and bringing care closer to the patient. For example, bioprinting can enable procedures such as skin grafting to be performed in a clinic rather than at specialized hospitals."

Table of Contents

Chapter One: Overview

  • 1.1. Background to Report: A Renaissance for Bioprinting?
  • 1.2. Bioprinting: An Attractive Business Opportunity Going Forward
    • 1.2.1. History and Prospects
    • 1.2.2. Bioprinting Industry Structure
    • 1.2.3. Evolution of the Bioprinting Industry
  • 1.3. Geographical Diversity of Companies
  • 1.4. Goal, Scope and Plan of this Report
  • 1.5. Methodology of this Report
    • 1.5.1. Forecasting Methodology and Assumptions
  • 1.6. Key Points from this Chapter

Chapter Two: Bioprinting: Market Drivers and Market Challenges

  • 2.1. Factors that Could Lead to the "Bioprinting Moment"
  • 2.2. The COVID Factor: COVID as a Bioprinting Market Driver
  • 2.3. The Aging Population: The Role of Bioprinting
  • 2.4. Bioprinting, Personalized Medicine and Bringing Healthcare Closer to the Patient
  • 2.5. New Technologies Emerge Since the Previous Bioprinting Moment
    • 2.5.1. Challenges to Technological Advances in Bioprinting
  • 2.6. The Growing Potential for Modeling
  • 2.7. Impact of Government Regulation and Funding
  • 2.8. A Broader Range of Bioinks
  • 2.9. Ethical Concerns with Bioprinting
  • 2.10. Key Points from this Chapter

Chapter Three: Bioprinters: Technical and Market Evolution

  • 3.1. The Essence of a Bioprinter
  • 3.2. Extrusion Bioprinters
    • 3.2.1. Examples of Extrusion Bioprinters
    • 3.2.2. The Future of Extrusion-based Bioprinting
  • 3.3. Inkjet Bioprinters
    • 3.3.1. Thermal Inkjet for Bioprinting
    • 3.3.2. Piezoelectric Inkjet for Bioprinting
    • 3.3.3. The Rastrum Bioprinter: An Example of an Inkjet Printer
  • 3.4. Stereolithography (SLA)
    • 3.4.1. The Problem with SLA-based Bioprinting
    • 3.4.2. Manufacturers of SLA Bioprinters
  • 3.5. Other Bioprinting Technologies
  • 3.6. Ten-year Forecasts of Bioprinter Markets by Printer Technology and Printer Type
    • 3.6.1. From Research Bioprinting to Biofabrication: A Forecast
  • 3.7. Key Points from this Chapter

Chapter Four: Bioinks

  • 4.1. Bioink Introductory
    • 4.1.1. Scaffold-based and Scaffold-free Bioprinting
    • 4.1.2. Hydrogels
    • 4.1.3. Stem Cells and Bioprinting
    • 4.1.4. Spheroids and Organoids
    • 4.1.5. Ceramics and Bioprinting
    • 4.1.6. A Note on Shear Printing
  • 4.2. Types of Bioinks: Functionality
    • 4.2.1. Sacrificial Bioinks
    • 4.2.2. Functional Bioinks
    • 4.2.3. Support Bioinks
  • 4.3. Materials for Bioinks
    • 4.3.1. Agarose
    • 4.3.2. Alginate
    • 4.3.3. Collagen
    • 4.3.4. Gelatin
    • 4.3.5. GelMA
    • 4.3.6. Chitosan
    • 4.3.7. Hyaluronic Acid
    • 4.3.8. dECM
    • 4.3.9. Fibrin
    • 4.3.10. Cellulose
    • 4.3.11. Silk
    • 4.3.12. Extracellular matrix (ECM)-based bioinks
    • 4.3.13. Role of Synthetic Polymers
    • 4.3.14. Smart Bioinks and Bioinks with Advanced Material Additives
  • 4.4. Phasing out Animal Materials
  • 4.5. Bioink Supply Chain and Suppliers
  • 4.6. Key Points from this Chapter

Chapter Five: Mainstream Bioprinting Applications

  • 5.1. Bioprinting Applications Analysis: Introductory
  • 5.2. Bioprinting and Improved Medical Modeling
    • 5.2.1. Organs-on-a-chip
    • 5.2.2. Disease Modeling
  • 5.3. Bioprinting Skin
    • 5.3.1. Background to Skin Grafting
    • 5.3.2. Bioprinting and Burn Victims
    • 5.3.3. Bioinks for Skin Bioprinting
    • 5.3.4. Cosmetics Testing
  • 5.4. Bone and Cartilage Printing
    • 5.4.1. Materials for Bone and Cartilage Printing
  • 5.5. Organ Printing and Vascular Printing
    • 5.5.1. Competition Between Printed Organs and Living Organs
    • 5.5.2. Bladder Printing
    • 5.5.3. Bioprinting and Breast Implants
    • 5.5.4. Liver Printing
    • 5.5.5. Endocrine System
    • 5.5.6. A Printed Pancreas
    • 5.5.7. Kidney Bioprinting
    • 5.5.8. Lungs
    • 5.5.9. Ears and Noses
    • 5.5.10. Eyes
    • 5.5.11. Hearts and Vasculature
    • 5.5.12. Bioprinting and Neural Tissue
  • 5.6. A Note on Dental Applications of Bioprinting
  • 5.7. Key Points from this Chapter

Chapter Six: New Directions in Bioprinting

  • 6.1. Introduction
  • 6.2. Soft Robotics
    • 6.2.1. Soft Robotics and Printing Using Biological Materials
  • 6.3. Food Printing
    • 6.3.1. Drivers for Food Printing
    • 6.3.2. Food Printers and Food Design
    • 6.3.3. Food Printers Currently Available
    • 6.3.4. Bioprinting Meat
    • 6.3.5. Printing Candies and Chocolates
    • 6.3.6. 3D Printing-Themed Restaurants
  • 6.4. Pill Printing
    • 6.4.1. Manufacturing of Pills Using 3D Printing: Advantages and Disadvantages
    • 6.4.2. Structure of a Growing Industry
  • 6.5. A Note on Medical Devices
  • 6.6. Key Points from this Report

Chapter Seven: Profiles of Nine Leading Bioprinting Firms and Their Strategies

  • 7.1. Criteria for Profiling
  • 7.2. 3DBio Therapeutics: Full Bioprinting Package for Healthcare Providers
  • 7.3. 3D Systems/Systemic Bio: Still Feeling its Way in the Bioprinting Business?
  • 7.4. BICO (Cellink): Bioconvergence Conglomerate
  • 7.5. Cyfuse - Japanese Bioprinting Firm
  • 7.6. EnvisionTEC/Desktop Metal: More Interest in Bioprinting
  • 7.7. FluidForm - Building Ties to Important Companies with Cutting Edge Technology
  • 7.8. Inventia Life Science: Breaking Out from R&D
  • 7.9. Organovo Holdings: More Focus Than Before
  • 7.10. Rokit Healthcare - Korean Bioprinting and Google Cloud

About SmarTech Analysis

About the Analyst

Acronyms and Abbreviations Used In this Report

List of Exhibits

  • Exhibit 1-1: Summary of the Bioprinting Market ($ Millions)
  • Exhibit 3-1: Bioprinter Markets by Class of Machine
  • Exhibit 3-2: Bioprinter Markets by Processing Technology
  • Exhibit 3-3: Bioprinter Markets by Role in Manufacturing Chain
  • Exhibit 4-1: Bioink Markets
  • Exhibit 5-1: Bioprinting Applications/Service Revenues ($ Millions)
  • Exhibit 6-1: Selected Food Printers